Who is BNGO competition?
Bionano Genomics (NASDAQ:BNGO) Vs. OLK, CTKB, QTRX, HLTH, BLI, OMIC, RPID, NAUT, ISO, and AKYA.
Is Bionano genomics profitable?
Given that Bionano Genomics didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth.
What industry is Bionano genomics?
life sciences instrumentation company
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Who owns Bionano genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.80% | 16,201,438 |
| The Vanguard Group, Inc. | 5.11% | 14,266,959 |
| SSgA Funds Management, Inc. | 2.70% | 7,522,852 |
| Geode Capital Management LLC | 1.67% | 4,672,052 |
What stock is similar to BNGO?
BNGO Similar Stocks Comparison
| By Industry: Diagnostics & Research | ||
|---|---|---|
| Symbol | Name | Current Price |
| AWH | Aspira Womens Health | 3.19 |
| AXDX | Accelerate Diagnostics | 6.31 |
| BDSX | Biodesix | 7.29 |
How many employees does BioNano Genomics?
How many employees does BioNano Genomics have? BioNano Genomics has 77 employees.
Will BNGO keep going up?
Bionano Genomics Inc quote is equal to 4.090 USD at 2021-11-26. Based on our forecasts, a long-term increase is expected, the “BNGO” stock price prognosis for 2026-11-20 is 28.518 USD. With a 5-year investment, the revenue is expected to be around +597.27%. Your current $100 investment may be up to $697.27 in 2026.
Is BNGO still a good stock?
The Big support level is between 5.95 to 6.07 (which is good after 2 positive days). BNGO will be flat most of the day and pick up at the closing bell and should close higher than 6.10……People Also Watch.
| Symbol | OCGN Ocugen, Inc. |
|---|---|
| Last Price | 10.06 |
| Change | -2.67 |
| % Change | -21.01% |
Will BNGO get FDA approval?
The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.
Should I buy BNGO?
The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
What institutions are buying NIO?
NIO (NYSE NIO) Institutional Buying and Selling American International Group Inc. Migdal Insurance & Financial Holdings Ltd. Global Wealth Management Investment Advisory Inc. National Asset Management Inc.
Will BioNano Genomics stock go up?
Will Bionano Genomics stock price grow / rise / go up? Yes. The BNGO stock price can go up from 4.090 USD to 9.181 USD in one year.